Latest news


Capital increase registered and listing of new shares

Posted on Apr 17, 2018

Oslo, 17 April 2018 – Reference is made to the stock exchange notice of 12 April 2018 by PCI Biotech Holding ASA (the “Company”) in respect of the issuance of 8,000 new shares following exercise of employee share options in the Company. The share capital increase resolved by the Board of Directors following the share option exercise on 12 April 2018, has now […]

Exercise of employee share options and resolution to increase the share capital

Posted on Apr 12, 2018

Oslo (Norway), 12 April 2018 – Exercise of employee share options and resolution to increase the share capital in PCI Biotech Holding ASA (the “Company”). 1. Options exercised One participant in the Company’s share option program has on 12th April 2018 exercised a total number of 5,000 share options at a strike price of NOK 9.11 […]

PCI Biotech: Full year 2017 report – a transformative year

Posted on Mar 20, 2018

Oslo (Norway), 20 March 2018 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its full year result. Please find enclosed the full year 2017 presentation. PCI Biotech Full Year 2017 Presentation 2017 was a year of significant progress for PCI Biotech. The year started with the completion of a strongly supported […]